The spectrum expanded: Cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 40, Issue 4, 2004, Pages 578-584

  Caldwell, Stephen H ^a   Crespo, Deborah M ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Belem Para   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; APOPTOSIS; CAUSE OF DEATH; CLINICAL FEATURE; CRYPTOGENIC CIRRHOSIS; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INFLAMMATION; LIPODYSTROPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MALLORY BODY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; REVIEW; SYMPTOM; WEIGHT REDUCTION;

EID: 1642355723     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.02.013     Document Type: Note

References (44)

1. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 37:2003;1202-1219.
2. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116:1999;1413-1419.
3. Hilden M., Juhl E., Thomsen A.C., Christoffersen P. Fatty liver persisting for up to 33 years. Acta Med Scand. 194:1973;485-489.
4. Teli M.R., James O.F.W., Burt A.D., Bennett M.K., Day C.P. The natural history of nonalcoholic fatty liver: a followup study. Hepatology. 22:1995;1714-1719.
5. Harrison S.A., Torgerson S., Hayashi P.H. The natural history of NAFLD: a clinical histopathological study. Am J Gastroenterol. 98:2003;2042-2047.
6. Fassio E., Alvarez E., Dominguez N., Landerira G., Longo C., Posadas A. Expanding knowledge on the natural history of nonalcoholic steatohepatitis: a longitudinal study of sequential liver biopsies. (abstract). Hepatology. 38:2003;231A.
7. Saksena S. Natural history and determinants of disease progression in non-alcoholic fatty liver disease: good and bad news. Hepatology. 38:2003;233A.
8. Byron D., Minuk G.Y. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology. 24:1996;813-815.
9. Greeve M., Ferrell L., Kim M., Combs C., Roberts J., Ascher N., et al. Cirrhosis of undefined pathogenesis: absence of evidence for unknown or autoimmune processes. Hepatology. 17:1993;593-598.
10. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 11:1990;74-80.
11. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 29:1999;664-669.
12. Poonawala A., Nair S.P., Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 32:2000;689-692.
13. Abdelmalek M., Ludwig J., Lindor K.D. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol. 20:1995;127-130.
14. Lee R.G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 20:1989;594-598.
15. Ludwig J., Viggiano T.R., McGill D.B., Ott B.J. Nonalcoholic steatohepatitis. Mayo Clin Proc. 55:1980;434-438.
16. Sasaki A., Horiuchi N., Hasegawa K., Uehara M. Mortality and causes of death in type 2 diabetic patients. Diabetes Res Clin Pract. 7:1989;33-40.
17. Kodali V.P., Gordon S.C., Silverman A.L., McGray D.G. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol. 89:1994;1836-1839.
18. Saunders J.B., Walters J.R., Davies A.P., Paton A. A twenty year prospective study of cirrhosis. Br Med J. 282:1981;263-266.
19. DiBisceglie A.M., Bacon B.R., Neuschwander-Tetri B.A., Yun A., Kim J.P. Role of hepatitis G virus in cryptogenic liver disease. Gastroenterology. 110:1996;A1181.
20. Strauss E., Lacet C.M.C., Caly W.R., Fukushima J.T., Gayotta L.C.C. Cryptogenic cirrhosis: clinical-biochemical comparison with alcoholic and viral etiologies. Arch Gastroenterol. 27:1990;46-52.
21. Stadheim L.M., O'Brien J.F., Lindor K.D., Gores G.J., McGill D.B. Value of determining carbohydrate deficient transferring isoforms in the diagnosis of alcoholic liver disease. Mayo Clin Proc. 78:2003;703-707.
22. Davies M.J., Baer D.J., Judd J.T., Brown E.D., Campbell W.S., Taylor P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women. JAMA. 287:2003;2559-2562.
23. Dixon J.B., Bathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 121:2001;91-100.
24. Contos M.J., Cales W., Sterling R.K., Lukeric V.A., Shiffman M.L., Mills A.S., et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 7:2001;363-373.
25. Ayata G., Gordon F.D., Lewis W.D., Pomfret E., Pomposelli J.J., Jenkins R.L., et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol. 33:2002;1098-1104.
26. Ong J., Younossi Z.M., Reddy V., Price L.L., Gramlich T., Mayes J., et al. Cryptogenic cirrhosis and post-transplantation nonalcoholic fatty liver disease. Liver Transpl. 7:2001;797-801.
27. Matsui O., Kadoya M., Takahashi S., Yoshikawa J., Gabata T., Takashima T., et al. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. Am J Roentgenol. 164:1995;1137-1140.
28. Schaffner F., Popper H. Capillarization of hepatic sinusoids. Gastroenterology. 44:1963;239-242.
29. Nosadini R., Avogaro A., Mollo F., Marescotti C., Tiengo A., Duner E., et al. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. J Clin Endocrinol Metab. 58:1984;1125-1132.
30. Caldwell S.H., Swerdlow R.H., Khan E.M., Iezzoni J.C., Hespenheide E., Oelsner D., et al. Mitochondrial abnormalities in NASH. J Hepatol. 31:1999;430-434.
31. Sanyal A.J., Campbell-Sargent C., Mirshani F., Rizzo W.B., Contons M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120:2001;1183-1192.
32. Caldwell S.H., Hespenheide E.E., Redick J.A., Iezzoni J.C., Battle E.H., Sheppard B.L. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol. 96:2001;519-525.
33. Holt I.J., Harding A.E., Petty R.K.H., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 46:1990;428-433.
34. Gines P., Quinteroa E., Arroyo V., Teres J., Bruguera M., Rimola A., et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 7:1987;122-128.
35. Ratzui V., Bonyhay L., Di Martino V., Charlotte F., Cavallaro L., Sayegh-Tainturier M.H., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 35:2002;1485-1493.
36. El-Serag H.B., Davila J.A., Petersen N.J., McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Int Med. 139:2003;817-823.
37. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 348:2003;1625-1638.
38. Ong J.P., Younossi Z.M. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis? Gastroenterology. 123:2002;375-378.
39. Cotrim H.P., Parana R., Braga E., Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol. 95:2000;3018-3019.
40. Zen Y., Katayanagi K., Tsuneyama K., Harada K., Araki I., Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int. 51:2001;127-131.
41. Yang S., Lin H.Z., Hwang J., Chacko V.P., Diehl A.M. Hepatocyte hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res. 61:2001;5016-5023.
42. Bugianasi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., et al. Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123:2002;134-140.
43. Marerro J.A., Fontana R.J., Su G.L., Conjeevarum H.A., Emick D.M., Lok A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the US. Hepatology. 36:2002;1349-1354.
44. Nair S., Mason A., Eason J., Loss G., Perillo R.P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 36:2002;150-155.